Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Marcelo F. Di Carli, MD, FACC
With
Mallinckrodt
Age
18–90
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Individuals aged 18 or older
Documentation of biopsy-proven sarcoidosis OR patients with typical findings on FDG PET and MRI without previous biopsy
Clinical suspicion of cardiac involvement defined as the presence of any of the following: high-degree A-V nodal block, complete bundle branch block, reduced left or right ventricular systolic function, any cardiac arrhythmia, and/or unexplained chest pain, dyspnea or syncope
PET/CT imaging demonstrating abnormal myocardial FDG uptake consistent with active inflammatory myocardium.
You may not be if
Initiation of steroids or any other immunosuppressive medication(s) following the completion of FDG-PET, as these medications, in theory, may subsequently suppress OctreoScan or DOTATATE uptake in the heart.
Patients with history of neuroendocrine tumors (specially insulinomas)
